140 Participants Needed

Digital vs. Analog Chest Drainage Systems for Pediatric Air Leak

(THOPAZ Trial)

CH
Overseen ByCatherine Hunter, MD
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: University of Oklahoma
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial compares digital and analog chest drainage systems for children with lung air leaks from conditions like spontaneous pneumothorax (a collapsed lung) or post-lung surgery. Researchers aim to determine if the digital system, which uses sensors to measure air leaks and maintain steady pressure, can reduce chest tube duration, the number of chest x-rays, and hospital stay length. Children under 18 who require a chest tube for these conditions at The Children's Hospital may qualify for this trial. As an unphased trial, it offers a unique opportunity to contribute to innovative research that could enhance future treatments for children with lung conditions.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What prior data suggests that these chest drainage systems are safe for pediatric patients?

Research has shown that digital chest drainage systems, such as the Thopaz+, are generally safe. Studies in adults suggest these systems help remove chest tubes more quickly and shorten hospital stays, indicating their safety. They use sensors to detect air leaks and adjust pressure, maintaining stability and safety.

Analog chest drainage systems lack precise measurement, which can lead to longer drainage times and variability in patient care. However, these systems have been used for a long time and are well-established in the medical field.

Both systems are generally well-tolerated, but the digital system may offer greater safety and comfort due to its precise measurements. So far, no major reports of serious side effects have emerged from either system.12345

Why are researchers excited about this trial?

Researchers are excited about the trial comparing digital and analog chest drainage systems for pediatric air leaks because these systems could potentially improve patient outcomes. The digital system, Thopaz+, stands out because it uses sensors to precisely measure air leaks and maintain constant negative pressure, which could lead to more consistent and quicker recovery times. Unlike traditional analog systems that rely on manual settings and subjective assessments of air leaks, the digital approach offers objective, real-time data that can help doctors decide the optimal time to remove the chest tube, potentially reducing hospital stays and healthcare costs. This trial aims to determine if these benefits seen in adults also apply to children, offering hope for better, more efficient care in pediatric patients.

What evidence suggests that digital chest tube drainage systems are effective for pediatric air leaks?

This trial will compare digital chest tube drainage systems, such as Thopaz+, with traditional analog systems for pediatric air leaks. Research has shown that digital systems can more accurately measure air leaks and maintain steady chest pressure, potentially leading to shorter drainage times and hospital stays. For adults, this also results in fewer chest x-rays and lower costs. Although studies on children are limited, early results suggest they might experience similar benefits. Traditional systems, in contrast, often take longer because they rely on manual pressure settings and personal judgment to assess air leaks.12367

Who Is on the Research Team?

CH

Catherine Hunter, MD

Principal Investigator

University of Oklahoma

Are You a Good Fit for This Trial?

This trial is for children and teens up to 17 years old who need a chest tube placed due to a collapsed lung or after lung surgery at The Children's Hospital. It excludes those with cancerous fluid in the lungs, recent chemo or radiation, major organ failure, brain function issues, pus in the lung cavity, adults over 18, or if the tube is placed by neonatologists or pediatricians.

Inclusion Criteria

I am 17 years old or younger.
I need a chest tube for a collapsed lung or lung surgery at The Children's Hospital.

Exclusion Criteria

I have fluid buildup due to cancer in the lining of my lung.
I have had chemotherapy or radiation in the last 12 months.
My child had a chest tube placed by a specialist.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants are randomized to either the digital (Thopaz+) or analog (Pleur-evac) drainage system and monitored for duration of chest tube drainage, length of stay, and air leaks.

Duration varies based on individual patient needs
Inpatient monitoring

Follow-up

Participants are monitored for safety and effectiveness after chest tube removal, including tracking of complications and recovery progress.

4 weeks

Data Analysis

Interim analysis will be performed once 12 patients per arm are accrued, with continued monitoring until the study is adequately powered.

Ongoing until study completion

What Are the Treatments Tested in This Trial?

Interventions

  • Analog Chest Tube Drainage System
  • Digital Chest Tube Drainage System (Thopaz+)
Trial Overview The study compares two types of chest drainage systems: Thopaz+ digital system versus traditional Atrium analog system. It aims to see if the digital system can reduce how long kids need a chest tube, cut down on X-rays needed and shorten air leak duration. This will be done through a randomized controlled trial—the first of its kind for this age group.
How Is the Trial Designed?
2Treatment groups
Active Control
Group I: Atrium Dry Suction Control Water Seal Chest DrainActive Control1 Intervention
Group II: Madela THOPAZ Suction PumpActive Control1 Intervention

Analog Chest Tube Drainage System is already approved in European Union, United States for the following indications:

🇪🇺
Approved in European Union as Conventional Chest Drainage System for:
🇺🇸
Approved in United States as Traditional Chest Tube Drainage System for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Oklahoma

Lead Sponsor

Trials
484
Recruited
95,900+

Published Research Related to This Trial

In a study of 60 patients with primary pneumothorax, the digital chest drainage system significantly reduced the average length of tube drainage to 2.2 days compared to 3.1 days for the conventional system, indicating improved efficacy.
Patients using the digital system reported higher satisfaction rates (about 90%) due to its convenience and real-time monitoring capabilities, suggesting it may enhance patient experience and facilitate better clinical decision-making.
The usefulness of Wi-Fi based digital chest drainage system in the post-operative care of pneumothorax.Cho, HM., Hong, YJ., Byun, CS., et al.[2020]
In a study of 26 pediatric patients undergoing pulmonary resection, the use of a digital thoracic drainage system significantly reduced the duration of chest tube use (1.69 days) compared to traditional drainage (5.38 days), indicating greater efficiency in postoperative care.
The digital system also led to fewer postoperative radiographs (2.8 vs. 6.23), suggesting it may streamline monitoring without compromising safety, as no complications were reported with its use.
Digital thoracic drainage: a new system to monitor air leaks in pediatric population.Pérez-Egido, L., García-Casillas, MA., Simal, I., et al.[2019]
In a study of 100 patients undergoing decortication for empyema thoracis, the Thopaz™ digital thoracic drain system significantly reduced air leak duration and the length of time chest tubes were needed compared to conventional drains.
Patients using the Thopaz system also had shorter hospital stays and fewer postoperative complications, suggesting it is a safer and more effective option for managing chest drainage after lung surgeries.
Use of thopaz in patients of empyema thoracis undergoing decortication.Alam, MS., Haseen, MA., Aslam, M., et al.[2022]

Citations

Comparative Analysis of Analog and Digital Chest Tube ...This study compares a three-chamber chest drainage system with a digital system using a high-fidelity 3D-printed model.
Comparative Analysis of Analog and Digital Chest Tube ...This study compares a three‐chamber chest drainage system with a digital system using a high‐fidelity 3D‐printed model.
Digital vs. Analog Chest Drainage Systems for Pediatric Air ...The investigators hypothesize that pediatric patients who are placed on the Thopaz+ digital drainage system will have decreased duration of chest tube drainage, ...
Comparison Between Electronic and Traditional Chest ...The aim of this study was to determine whether the use of digital chest drain systems, compared with traditional ones, reduced the duration of chest drainage.
Promising Effects of Digital Chest Tube Drainage System ...Conclusions: Digital CTDS is associated with better outcomes than suction and non-suction CTDS for patients undergoing pulmonary resections, ...
Drainology: Leveraging research in chest-drain management ...Three preliminary studies have suggested that digital systems are safe to use in cardiac surgery patients and are associated with reduced air leak, more ...
A Systematic Review of Digital Versus Analog Drainage for Air ...33,37 The mean chest tube duration ranged from 47 to 96 hours with the digital system and from 74 to 94 hours with the analog system. Hospital Length of Stay:.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security